The NHS criteria are stricter, and lower BMI thresholds apply for South Asian, Chinese, Other Asian, Middle Eastern, Black African, and African-Caribbean backgrounds 3
9,11,20 Some studies have suggested that GLP-1RA medications may reduce the incidence of gastrointestinal cancers, 4 such as colorectal cancer
Thanks to a mechanism that stimulates insulin and reduces glucagon secretions in a glucose-dependent manner, semaglutide has been shown to reduce fasting and postprandial blood glucose levels
Patients experiencing new neurological symptoms, persistent fatigue, or signs of anaemia during GLP-1/GIP treatment should contact their GP for B12 assessment